Published

Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Handbook of experimental pharmacology
Date: 2018-01-01
Source: PubMed
DOI: 10.1007/164_2018_107
PubMed: 29532180

Authors

Canal CE

Watch author

Derived topics and classifications

psilocybin Depression Brain Imaging Pharmacology Mechanism of Action Receptor Pharmacology Aging Clinical Trial Animal Study Treatment-Resistant Depression Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Chronic pain education: past, present, and future of psychedelics for the management of chronic painPain Medicine · 2024-12-10 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-06-01 Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01 An Examination of Psilocybin Effects on Biomarkers of Longevity, Healthy Aging, and Purpose in LifeClinicalTrials.gov · 2026-08-17 Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring OpioidsClinicalTrials.gov · 2026-08-12 Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin (NECTAR) in Aging and Alzheimer's DiseaseClinicalTrials.gov · 2026-08-07 The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive DisorderClinicalTrials.gov · 2026-08-13 Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23